用结构适应的真菌蛋白纤维素接种疫苗可以诱导对帕金森病的免疫力
Verena Pesch1, José Miguel Flores-Fernandez2, Sara Reithofer1
1Institut für Biologische Informationsprozesse, Strukturbiochemie (IBI-7), Forschungszentrum Jülich, 52425 Jülich, Germany.
Brain : a journal of neurology
|March 1, 2024
概括
针对错误折叠的α-synuclein纤维的新型疫苗在帕金森病方面表现有前途. 免疫接种在小鼠模型中延长了生存时间,为同核蛋白病变和其他粉样蛋白疾病提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 帕金森病是一种神经退行性疾病,由病理性α-synuclein错误折叠和聚合引起.
- 目前,帕金森病没有治愈方法,这凸显了对新型治疗策略的需求.
研究的目的:
- 开发针对特定形状的针对alpha-synuclein纤维的疫苗.
- 为了评估这些疫苗在预防或治疗帕金森病模型中的有效性.
主要方法:
- 将真菌蛋白HET-s ((218-298) 改造为具有特定表位的四种纤维状疫苗候选物.
- 接种了TgM83+/-的小鼠,并用α-synuclein纤维素对它们进行了挑战,以模拟帕金森病.
- 评估了对α-synuclein纤维和患者大脑同质物的生存率和抗体识别.
主要成果:
- 接种疫苗延长了与α-synuclein纤维素有挑战的小鼠的存活时间,在体为先的模型 (21-22%) 和脑为先的模型 (8%) 中观察到显著增加.
- 抗体产生了已知的病理性α-synuclein纤维素和来自帕金森病,勒维体痴呆症和多个系统缩患者的大脑组织.
结论:
- 针对病理性α-synuclein纤维素的形状特异性疫苗提供了一个有希望的治疗方法.
- 这些疫苗有可能保护人们免受帕金森病,相关的同核蛋白病变和其他氨基原蛋白误折叠障碍.
相关概念视频
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:15Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
01:51Vaccinations
44.5K
Overview
44.5K
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K